-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Lowers Price Target to $9.5

Benzinga·03/25/2026 13:15:26
Listen to the news
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and lowers the price target from $11 to $9.5.